Catalyst

Slingshot members are tracking this event:

U.S Department of Health Issues $30.5M Task Order to Emergent Bio (EBS) to Develop Therapeutics for Viral Hemorrhagic Fever

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
EBS

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 13, 2017
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords U.s. Department Of Health And Human Services, Barda, Hemorrhagic Fever